Skip to main content
. 2020 Sep 2;61(6):842–850. doi: 10.1093/jrr/rraa062

Fig. 4.

Fig. 4.

The protein expression of NLRP3 and the concentration of IL-1β and TNF-α in control, MSU and rosiglitazone groups. (A) IL -1β expression level; (B) representative western blots showing the effects of rosiglitazone on NLRP3; (C) TNF-α expression level; (D) relative NLRP3 protein level. Each experiment was repeated at least three times (one-way ANOVA followed by a Tukey–Kramer multiple comparisons post test).